Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation

Compensation costs that have been included in our condensed consolidated statements of operations for all stock-based compensation arrangements is set forth below:


		Three months ended March 31,
(in thousands)		2026				2025
Cost of revenue			17				15
Sales and marketing			9				8
General and administrative			78				67
Research and development			8				(4	)
Total stock-based compensation		$	112			$	86

Schedule of Restricted Stock Unit Activity

A summary of our restricted stock unit activity for the three months ended March 31, 2026 is set forth below:


		Shares				Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2025			17,732			$	21.17
Granted			9,526				1.76
Released			(5,306	)			15.61
Forfeited			-				-
Outstanding as of March 31, 2026			21,952			$	14.09

Schedule of Stock Option Activity

A summary of our stock option activity under the 2018 Equity Incentive Plan (the “2018 Plan) and related information is as follows:


		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding as of December 31, 2025			1,000			$	85.00
Granted			-				-
Exercised			-				-
Forfeited			-			$	-
Outstanding as of March 31, 2026			1,000			$	85.00			6.36		$	-
Exercisable as of March 31, 2026			1,000			$	85.00			6.36		$	-

A summary of our option activity under our 2009 Equity Incentive Plan (the “2009 Plan”) and related information is as follows:


		Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2025			883			$	113.56
Granted			-				-
Exercised			-				-
Forfeited			-				-
Outstanding as of March 31, 2026			883			$	113.56				2.00			$	-
Exercisable as of March 31, 2026			883			$	113.56				2.00			$	-